Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 23, 2018

DrugPatentWatch Database Preview

VEINAMINE 8% Drug Profile

« Back to Dashboard

When do Veinamine 8% patents expire, and when can generic versions of Veinamine 8% launch?

Veinamine 8% is a drug marketed by Hospira Inc and is included in one NDA.

The generic ingredient in VEINAMINE 8% is amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate. There are three hundred and forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate profile page.

Summary for VEINAMINE 8%

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	VEINAMINE 8% at DailyMed

Drug patent expirations by year for VEINAMINE 8%

Pharmacology for VEINAMINE 8%

Ingredient-type	Amino Acids
Drug Class	Amino Acid

US Patents and Regulatory Information for VEINAMINE 8%

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira Inc	VEINAMINE 8%	amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate	INJECTABLE;INJECTION	017957-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission

AstraZeneca

Covington

Dow

Boehringer Ingelheim

Cantor Fitzgerald

Julphar

Cipla

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.